<--- Back to Details
First PageDocument Content
Myeloid leukemia / Acute myeloid leukemia / Fanconi anemia / Myelodysplastic syndrome / Leukemia / MECOM / Hematological malignancy / RUNX1 / Guido Fanconi / Oncology / Medicine / Acute leukemia
Date: 2014-06-02 11:49:22
Myeloid leukemia
Acute myeloid leukemia
Fanconi anemia
Myelodysplastic syndrome
Leukemia
MECOM
Hematological malignancy
RUNX1
Guido Fanconi
Oncology
Medicine
Acute leukemia

Pediatr Blood Cancer BRIEF REPORT Patients With Fanconi Anemia and AML Have Different Cytogenetic Clones Than De Novo Cases of AML Andrzej Rochowski, MD,1,2 Susan B. Olson, PhD,3 Todd A. Alonzo, PhD,4

Add to Reading List

Source URL: www.fanconi.org

Download Document from Source Website

File Size: 64,24 KB

Share Document on Facebook

Similar Documents

Clinical Neutron Therapy System Reference Manual Jonathan Jacky1 Ruedi Risler Radiation Oncology, Box

Clinical Neutron Therapy System Reference Manual Jonathan Jacky1 Ruedi Risler Radiation Oncology, Box

DocID: 1xVse - View Document

Formal Development of a Graphical User Interface for a Radiation Therapy Machine Jonathan Jacky  Jonathan Unger Radiation Oncology Department RC-08 University of Washington

Formal Development of a Graphical User Interface for a Radiation Therapy Machine Jonathan Jacky  Jonathan Unger Radiation Oncology Department RC-08 University of Washington

DocID: 1xViy - View Document

Experience with Z Developing a Control Program for a Radiation Therapy Machine Jonathan Jacky , Jonathan Unger, Michael Patrick and Ruedi Risler Radiation Oncology Box

Experience with Z Developing a Control Program for a Radiation Therapy Machine Jonathan Jacky , Jonathan Unger, Michael Patrick and Ruedi Risler Radiation Oncology Box

DocID: 1xV2d - View Document

Formal Specication and Development of Control System Input/Output Jonathan Jacky Radiation Oncology Department RC-08 University of Washington

Formal Speci cation and Development of Control System Input/Output Jonathan Jacky Radiation Oncology Department RC-08 University of Washington

DocID: 1xUvZ - View Document

European Society for Medical Oncology (ESMOCongress Roche Analyst Audio Webcast Monday, 22 October 2018 Welcome Daniel O’Day, CEO Roche Pharmaceuticals

European Society for Medical Oncology (ESMOCongress Roche Analyst Audio Webcast Monday, 22 October 2018 Welcome Daniel O’Day, CEO Roche Pharmaceuticals

DocID: 1xTgE - View Document